Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease.

Augustin, Salvador; Pons, Mònica; Maurice, James B; Bureau, Christophe; Stefanescu, Horia; Ney, Michel; Blasco, Hélène; Procopet, Bogdan; Tsochatzis, Emmanuel; Westbrook, Rachel H; Bosch, Jaime; Berzigotti, Annalisa; Abraldes, Juan G; Genescà, Joan (2017). Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology, 66(6), pp. 1980-1988. Wiley Interscience 10.1002/hep.29363

[img] Text
Augustin_et_al-2017-Hepatology.pdf - Published Version
Restricted to registered users only
Available under License Publisher holds Copyright.

Download (289kB) | Request a copy

Patients with compensated advanced chronic liver disease (cACLD) can safely avoid screening endoscopy with a platelet count >150 × 109 cells/L and a liver stiffness measurement (LSM) <20 kPa (Baveno VI criteria). However, the total number of avoided endoscopies using this rule is relatively low. We aimed at expanding the Baveno VI criteria and validating them in additional cohorts. Patients from the Anticipate cohort (499 patients with cACLD of different etiologies) were used to study the performance of different thresholds of platelets and LSM for the identification of patients at very low risk (<5%) of having varices needing treatment (VNT). The new criteria (Expanded-Baveno VI) were validated in two additional cohorts from London (309 patients) and Barcelona (117 patients). The performance of the new criteria by etiology of cACLD was also assessed. The best new expanded classification rule was platelet count >110 × 109 cells/L and LSM <25 kPa. This was validated in the two additional cohorts. Overall, the Expanded-Baveno VI criteria would potentially spare 367 (40%) endoscopies (21% with Baveno VI criteria) with a risk of missing VNT of 1.6% (95% confidence interval, 0.7%-3.5%) in patients within the criteria and 0.6% (95% confidence interval, 0.3%-1.4%) in the overall population of 925 patients evaluated. The Expanded-Baveno VI criteria performed well in patients with cACLD with hepatitis C virus and alcoholic and nonalcoholic steatohepatitis. CONCLUSION The new Expanded-Baveno VI criteria spare more endoscopies than the original criteria with a minimal risk of missing VNT in most of the main etiologies of cACLD. (Hepatology 2017;66:1980-1988).

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Visceral Surgery and Medicine > Hepatology

UniBE Contributor:

Bosch, Jaime and Berzigotti, Annalisa

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0270-9139

Publisher:

Wiley Interscience

Language:

English

Submitter:

Thi Thao Anh Pham

Date Deposited:

30 Jan 2018 13:29

Last Modified:

30 Jan 2018 13:29

Publisher DOI:

10.1002/hep.29363

PubMed ID:

28696510

BORIS DOI:

10.7892/boris.109573

URI:

https://boris.unibe.ch/id/eprint/109573

Actions (login required)

Edit item Edit item
Provide Feedback